These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21803755)

  • 1. Impact of device-guided slow breathing on symptoms of chronic heart failure: a randomized, controlled feasibility study.
    Ekman I; Kjellström B; Falk K; Norman J; Swedberg K
    Eur J Heart Fail; 2011 Sep; 13(9):1000-5. PubMed ID: 21803755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Device-guided paced breathing in the home setting: effects on exercise capacity, pulmonary and ventricular function in patients with chronic heart failure: a pilot study.
    Parati G; Malfatto G; Boarin S; Branzi G; Caldara G; Giglio A; Bilo G; Ongaro G; Alter A; Gavish B; Mancia G
    Circ Heart Fail; 2008 Sep; 1(3):178-83. PubMed ID: 19808287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial.
    Oxberry SG; Torgerson DJ; Bland JM; Clark AL; Cleland JG; Johnson MJ
    Eur J Heart Fail; 2011 Sep; 13(9):1006-12. PubMed ID: 21712288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating hypertension in type II diabetic patients with device-guided breathing: a randomized controlled trial.
    Schein MH; Gavish B; Baevsky T; Kaufman M; Levine S; Nessing A; Alter A
    J Hum Hypertens; 2009 May; 23(5):325-31. PubMed ID: 19005477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of inspiratory muscle training in patients with heart failure.
    Bosnak-Guclu M; Arikan H; Savci S; Inal-Ince D; Tulumen E; Aytemir K; Tokgözoglu L
    Respir Med; 2011 Nov; 105(11):1671-81. PubMed ID: 21621993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
    Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
    J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cardiac resynchronization therapy-defibrillator implantation on health status in patients with mild versus moderate symptoms of heart failure.
    Versteeg H; van den Broek KC; Theuns DA; Mommersteeg PM; Alings M; van der Voort PH; Jordaens L; Pedersen SS
    Am J Cardiol; 2011 Oct; 108(8):1155-9. PubMed ID: 21821227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of physical training in chronic heart failure].
    Andersen K; Jónsdóttir S; Sigurethsson AF; Sigurethsson SB
    Laeknabladid; 2006 Nov; 92(11):759-64. PubMed ID: 17093327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
    Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure.
    MacIver J; Rao V; Delgado DH; Desai N; Ivanov J; Abbey S; Ross HJ
    J Heart Lung Transplant; 2008 Sep; 27(9):1002-7. PubMed ID: 18765193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure.
    De Ferrari GM; Crijns HJ; Borggrefe M; Milasinovic G; Smid J; Zabel M; Gavazzi A; Sanzo A; Dennert R; Kuschyk J; Raspopovic S; Klein H; Swedberg K; Schwartz PJ;
    Eur Heart J; 2011 Apr; 32(7):847-55. PubMed ID: 21030409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home telemonitoring of vital signs and cardiorespiratory signals in heart failure patients: system architecture and feasibility of the HHH model.
    Pinna GD; Maestri R; Andrews D; Witkowski T; Capomolla S; Scanferlato JL; Gobbi E; Ferrari M; Ponikowski P; Sleight P; Mortara A; Johnson P
    Int J Cardiol; 2007 Sep; 120(3):371-9. PubMed ID: 17189654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
    Pires LA; Abraham WT; Young JB; Johnson KM;
    Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.
    Pappone C; Augello G; Rosanio S; Vicedomini G; Santinelli V; Romano M; Agricola E; Maggi F; Buchmayr G; Moretti G; Mika Y; Ben-Haim SA; Wolzt M; Stix G; Schmidinger H
    J Cardiovasc Electrophysiol; 2004 Apr; 15(4):418-27. PubMed ID: 15089990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiopulmonary exercise test is safe and reliable in elderly patients with chronic heart failure.
    Scardovi AB; Coletta C; De Maria R; Perna S; Aspromonte N; Feola M; Rosso G; Greggi M; Ceci V
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):608-12. PubMed ID: 17667032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.